• Pharmaceutical companies are accelerating air freight of medicines to the U.S. to avoid potential 25% tariffs.
  • The Trump administration could announce tariffs as early as April 2025, disrupting fragile drug supply chains.
  • Industry warns of higher drug prices and shortages, with 90% of biotech firms relying on imported materials.

Rush to beat tariff deadline

Pharmaceutical firms are quietly shifting more medicine shipments to air cargo routes in what logistics executives describe as a "preemptive strike" against looming U.S. tariffs. Multiple supply chain sources confirm seeing a 15-20% increase in pharmaceutical air freight volumes in recent weeks, particularly for high-value biologics and specialty drugs.

"We're seeing clients front-load inventory," said one logistics manager at a major cargo airline who requested anonymity due to client confidentiality. "The math changes dramatically if a $100,000 biologic treatment suddenly costs $125,000 at customs."

Fragile supply chains at risk

The potential tariffs—which could be announced as early as April 2025—threaten to upend carefully calibrated just-in-time delivery systems for temperature-sensitive medicines. Industry analysts note that 44% of companies expect needing more than two years to reconfigure supply chains if tariffs take effect.

"You can't just flip a switch and move biologics production," said a generic drug executive who declined to be named. "We're talking about products with 18-month lead times and complex cold chain requirements."

Market reactions

While Eli Lilly and Johnson & Johnson have announced major U.S. manufacturing investments, most companies are taking stopgap measures. Some are negotiating "tariff-sharing" agreements with distributors, while others are accelerating FDA approvals for alternative manufacturing sites.

Pharma logistics teams report scrambling to secure temperature-controlled air cargo capacity, with one major handler noting a 30% premium on certain routes. "It's like the early COVID vaccine rush all over again," the handler said, "except this time we see it coming."